Aglaia is an investment fund fully focused on the fight against cancer and the development of improved anti-cancer drugs in particular. Aglaia has a proven ability to select and mature early-stage breakthrough inventions that have the potential to transform cancer treatment. For more information, please visit www.aglaia-oncology.com
Looking for a particular Aglaia Oncology Funds employee's phone or email?
The Aglaia Oncology Funds annual revenue was $1 million in 2026.
Karl Rothweiler is the Managing Partner of Aglaia Oncology Funds.
3 people are employed at Aglaia Oncology Funds.
The NAICS codes for Aglaia Oncology Funds are [52, 54, 523, 54171, 5417, 541711, 541].
The SIC codes for Aglaia Oncology Funds are [67, 679, 6799].